Opportunity ID: 130973

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-12-015
Funding Opportunity Title: Alzheimer’s Disease Drug Development Program (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 16, 2011
Last Updated Date:
Original Closing Date for Applications: Jan 07, 2015
Current Closing Date for Applications: Jan 07, 2015
Archive Date: Feb 07, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Special district governments
Independent school districts
Private institutions of higher education
State governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this funding opportunity announcement (FOA) is to support pre-clinical development of new therapies aimed at modifying the behavioral symptoms in Alzheimer’s disease (AD); or delaying the onset or slowing the progression of AD, mild cognitive impairment (MCI), or age-related cognitive decline. This program is specifically directed at projects focused on the optimization of therapeutic leads with demonstrated activity against an intended disease target. Projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the funding period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research and basic, mechanistic research. This is a milestone-driven cooperative agreement program involving participation of NIA program staff both in the development of the project plan and monitoring of research progress.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-12-015.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.866 ADOBE-FORMS-B2 ADOBE-FORMS-B2 PKG00085790 Jan 05, 2012 Sep 24, 2013 View
93.866 FORMS-C Use for due dates after 9/24/2013 PKG00180686 Sep 08, 2013 Jan 07, 2015 View

Package 1

Mandatory forms

130973 RR_SF424_1_2-1.2.pdf

130973 PerformanceSite_1_4-1.4.pdf

130973 RR_OtherProjectInfo_1_3-1.3.pdf

130973 RR_KeyPersonExpanded_1_2-1.2.pdf

130973 PHS398_CoverPageSupplement_1_4-1.4.pdf

130973 PHS398_ResearchPlan_1_3-1.3.pdf

130973 PHS398_Checklist_1_3-1.3.pdf

Optional forms

130973 RR_SubawardBudget30-1.2.pdf

130973 PHS398_ModularBudget_1_2-1.2.pdf

130973 RR_Budget-1.1.pdf

130973 PHS_CoverLetter_1_2-1.2.pdf

Package 2

Mandatory forms

130973 RR_SF424_2_0-2.0.pdf

130973 PHS398_ResearchPlan_2_0-2.0.pdf

130973 PHS398_CoverPageSupplement_2_0-2.0.pdf

130973 RR_KeyPersonExpanded_2_0-2.0.pdf

130973 RR_OtherProjectInfo_1_3-1.3.pdf

130973 PerformanceSite_2_0-2.0.pdf

Optional forms

130973 RR_SubawardBudget30_1_3-1.3.pdf

130973 PlannedReport-1.0.pdf

130973 PHS398_CumulativeInclusionReport-1.0.pdf

130973 PHS398_ModularBudget_1_2-1.2.pdf

130973 RR_Budget_1_3-1.3.pdf

2025-07-13T19:32:38-05:00

Share This Post, Choose Your Platform!

About the Author: